CIK: 0001388551 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value ($000): $72,463 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 135,186 | $27,783 | 38.3% | — | — | Put | 78462F103 |
| — | CELATOR PHARMACEUTICALS INC | 2,322,769 | $25,620 | 35.4% | $3.51 | — | COM | 15089R102 |
| — | AGILE THERAPEUTICS INC | 1,428,871 | $8,873 | 12.2% | $6.24 | — | COM | 00847L100 |
| — | SYNTA PHARMACEUTICALS CORP | 21,704,847 | $5,209 | 7.2% | $6.65 | — | COM | 87162T206 |
| BRK/B | BERKSHIRE HATHAWAY INC DEL | 9,116 | $1,293 | 1.8% | $132.86 | -0.2% | CL B NEW | 084670702 |
| — | AMERICAN CAP LTD | 68,537 | $1,044 | 1.4% | $14.60 | — | COM | 02503Y103 |
| IWM | ISHARES TR | 5,338 | $591 | 0.8% | — | — | Put | 464287655 |
| CSW | CSW INDUSTRIALS INC | 10,906 | $344 | 0.5% | $30.94 | 0.0% | COM | 126402106 |
| SCM | STELLUS CAP INVT CORP | 23,489 | $240 | 0.3% | $10.61 | -14.7% | COM | 858568108 |
| — | CM FIN INC | 28,220 | $237 | 0.3% | $9.37 | — | COM | 12574Q103 |
| — | KARYOPHARM THERAPEUTICS INC | 24,829 | $221 | 0.3% | $8.90 | — | COM | 48576U106 |
| DOV | DOVER CORP | 3,285 | $211 | 0.3% | $40.98 | 0.0% | COM | 260003108 |
| — | MEDLEY CAP CORP | 27,093 | $179 | 0.2% | $8.19 | — | COM | 58503F106 |
| ABUS | ARBUTUS BIOPHARMA CORP | 41,903 | $173 | 0.2% | $4.93 | -27.5% | COM | 03879J100 |
| — | CIDARA THERAPEUTICS INC | 12,812 | $163 | 0.2% | $17.17 | — | COM | 171757107 |
| — | AMERICAN CAP SR FLOATING LTD | 15,457 | $155 | 0.2% | $9.84 | — | COM | 02504D108 |
| — | ASSEMBLY BIOSCIENCES INC | 22,185 | $111 | 0.2% | $7.05 | — | COM | 045396108 |
| — | SYNTA PHARMACEUTICALS CORP | 67,000 | $16 | 0.0% | $6.65 | — | Call | 87162T206 |